However, patients and healthcare professionals have increasingly noted concerns about hair changes during treatment, prompting questions about whether these medications directly affect hair growth and follicle health
Editorial: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have potential to transform health outcomes for persons with bipolar disorder, schizophrenia, major depressive disorder and other serious mental illnesses by lengthening healthspan and reducing excess and premature mortality
If you miss more than one dose, give us a call so we can provide you with personalized guidance
Compounded semaglutide and brand-name formulations contain the same active molecule, so the core neurochemical effects should be similar
He is uniquely qualified to explain how GLP-1 RAs are changing the landscape for patients with and without diabetes and their providers
doi:10.1016/j.xops.2024.100547 23